{
    "clinical_study": {
        "@rank": "110998", 
        "acronym": "ESPX", 
        "arm_group": [
            {
                "arm_group_label": "PIOLIN\u00ae", 
                "arm_group_type": "Experimental", 
                "description": "PIOLIN\u00ae SHAMPOO 5 DAYS CONTINUOUSLY STOP A WEEK AND APPLY AGAIN"
            }, 
            {
                "arm_group_label": "NEDAX", 
                "arm_group_type": "Active Comparator", 
                "description": "FOLLOWING THE LEAFLET TREATMENT"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims to demonstrate the therapeutic efficacy and safety of Shampoo PIOLIN \u00ae in\n      the treatment of human pediculosis. Will be treated 212 patients aged 2-60 years with the\n      infestation, along with the people in your family life. All will be submitted to the dosing\n      regimen recommended in the package insert. 100% of the sample shall be subjected to clinical\n      evaluation through comb, pre and post treatment and monitored after thirty days for\n      evaluation of safety and possible adverse effects that may arise related to any of the\n      components of the formula.\n\n      The efficacy study is active comparator, non-inferiority."
        }, 
        "brief_title": "Efficacy and Safety Study for PIOLIN\u00ae Shampoo", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "PEDICULOSIS", 
        "condition_browse": {
            "mesh_term": "Lice Infestations"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Volunteers healthy female and male ;\n\n          -  Children between 2 and 17 years ;\n\n          -  Increased from 18 years;\n\n          -  Availability of volunteer to maintain a stable weight during the study period\n             (ranging from less than 2 kg) ;\n\n          -  Displays lice infestation on clinical examination ;\n\n          -  Voluntary participation ;\n\n          -  Signing the consent form and / or Free and Informed Consent ;\n\n          -  Willingness to comply with study procedures ;\n\n          -  Complying that researchers can make use of all the information nameless , including\n             publication and comply with the use and storage of all information confidential .\n\n        Exclusion Criteria:\n\n          -  Use paint or other chemicals on the hair in the last four weeks that precede the\n             study ;\n\n          -  Concomitant Therapy ;\n\n          -  Women who are pregnant or intend to become pregnant during the study ;\n\n          -  Infants ;\n\n          -  Volunteers not willing to sign and adhere to the Statement of Consent ;\n\n          -  Known hypersensitivity to the product ;\n\n          -  Participation in any other clinical study ;\n\n          -  Any other condition that the investigator decides that might interfere with the\n             results or involving a risk to the volunteer study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "212", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01966965", 
            "org_study_id": "ESPX2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "PIOLIN\u00ae", 
                "description": "PIOLIN\u00ae SHAMPOO 5 DAYS CONTINUOUSLY STOP A WEEK AND APPLY AGAIN", 
                "intervention_name": "PIOLIN\u00ae", 
                "intervention_type": "Drug", 
                "other_name": "RUTA GRAVEOLENS STANDARDIZED FLUID EXTRACT"
            }, 
            {
                "arm_group_label": "NEDAX", 
                "description": "AS SPECIFIED AT THE LEAFLET", 
                "intervention_name": "NEDAX", 
                "intervention_type": "Drug", 
                "other_name": "PERMETRIN"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "PIOLIN\u00ae, PEDICULOSIS, EFFICACY, SAFETY, PHYTOMEDICINE,", 
            "ARRUDA, RUTA"
        ], 
        "lastchanged_date": "October 22, 2013", 
        "link": {
            "description": "Brazilian researchers and professors site", 
            "url": "http://lattes.cnpq.br/8425815106310226"
        }, 
        "location": {
            "contact": {
                "email": "MONIKETHI@GMAIL.COM", 
                "last_name": "MONICA M MENDES, MD MSc", 
                "phone": "55 53 9155-2139"
            }, 
            "facility": {
                "address": {
                    "city": "Pelotas", 
                    "country": "Brazil", 
                    "state": "RS", 
                    "zip": "96075-540"
                }, 
                "name": "Ubs Fatima"
            }, 
            "investigator": {
                "last_name": "MONICA M MENDES, MD MSc", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase 3 Efficacy and Safety Study for PIOLIN\u00ae Shampoo to Treat Pediculosis", 
        "overall_contact": {
            "email": "karla@phytopharm.com.br", 
            "last_name": "KARLA F DEUD JOS\u00c9, PharmD PhD", 
            "phone": "55 51 9279-3075"
        }, 
        "overall_contact_backup": {
            "email": "karladeud@gmail.com", 
            "last_name": "Karla F Deud Jos\u00e9, PharmD PhD", 
            "phone": "55 51 3231-7876"
        }, 
        "overall_official": [
            {
                "affiliation": "UCPEL-UNIVERSIDADE CAT\u00d3LICA DE PELOTAS", 
                "last_name": "MONICA M MENDES, MD MSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "INDEPENDENT", 
                "last_name": "ACHILLES GENTILINI NETO, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Brazil: National Committee of Ethics in Research", 
                "Brazil: National Health Surveillance Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "AFTER 17 DAYS OF TREATMENT PATIENTS SHOULD HAVE NO INFESTATION - clinically", 
            "measure": "EFFICACY", 
            "safety_issue": "No", 
            "time_frame": "17 DAYS"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01966965"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Phytopharm Consulting Brazil", 
            "investigator_full_name": "Karla F. Deud Jose", 
            "investigator_title": "CEO", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "IN THE END OF 30 DAYS TREATMENT PATIENTS WILL BE EVALUATED WITH BLOOD/URINE ANALYSIS FOR CHECKING ANY CHANGE - biochemistry, lab exams", 
            "measure": "SAFETY", 
            "safety_issue": "Yes", 
            "time_frame": "30 DAYS"
        }, 
        "source": "Phytopharm Consulting Brazil", 
        "sponsors": {
            "collaborator": {
                "agency": "Laborat\u00f3rio Sa\u00fade Ltda - principal e \u00fanico patrocinador", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Phytopharm Consulting Brazil", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}